121 related articles for article (PubMed ID: 28041995)
1. Osteoprotegerin and β
Dufresne SS; Boulanger-Piette A; Frenette J
Am J Pathol; 2017 Mar; 187(3):498-504. PubMed ID: 28041995
[TBL] [Abstract][Full Text] [Related]
2. Power output of fast and slow skeletal muscles of mdx (dystrophic) and control mice after clenbuterol treatment.
Lynch GS; Hinkle RT; Faulkner JA
Exp Physiol; 2000 May; 85(3):295-9. PubMed ID: 10825417
[TBL] [Abstract][Full Text] [Related]
3. IGF-I treatment improves the functional properties of fast- and slow-twitch skeletal muscles from dystrophic mice.
Lynch GS; Cuffe SA; Plant DR; Gregorevic P
Neuromuscul Disord; 2001 Apr; 11(3):260-8. PubMed ID: 11297941
[TBL] [Abstract][Full Text] [Related]
4. Genetic deletion of muscle RANK or selective inhibition of RANKL is not as effective as full-length OPG-fc in mitigating muscular dystrophy.
Dufresne SS; Boulanger-Piette A; Bossé S; Argaw A; Hamoudi D; Marcadet L; Gamu D; Fajardo VA; Yagita H; Penninger JM; Russell Tupling A; Frenette J
Acta Neuropathol Commun; 2018 Apr; 6(1):31. PubMed ID: 29699580
[TBL] [Abstract][Full Text] [Related]
5. Osteoprotegerin protects against muscular dystrophy.
Dufresne SS; Dumont NA; Bouchard P; Lavergne É; Penninger JM; Frenette J
Am J Pathol; 2015 Apr; 185(4):920-6. PubMed ID: 25708645
[TBL] [Abstract][Full Text] [Related]
6. Making fast-twitch dystrophic muscles bigger protects them from contraction injury and attenuates the dystrophic pathology.
Gehrig SM; Koopman R; Naim T; Tjoakarfa C; Lynch GS
Am J Pathol; 2010 Jan; 176(1):29-33. PubMed ID: 19959813
[TBL] [Abstract][Full Text] [Related]
7. Expression of dystrophin driven by the 1.35-kb MCK promoter ameliorates muscular dystrophy in fast, but not in slow muscles of transgenic mdx mice.
Dunant P; Larochelle N; Thirion C; Stucka R; Ursu D; Petrof BJ; Wolf E; Lochmüller H
Mol Ther; 2003 Jul; 8(1):80-9. PubMed ID: 12842431
[TBL] [Abstract][Full Text] [Related]
8. Systemic administration of beta2-adrenoceptor agonists, formoterol and salmeterol, elicit skeletal muscle hypertrophy in rats at micromolar doses.
Ryall JG; Sillence MN; Lynch GS
Br J Pharmacol; 2006 Mar; 147(6):587-95. PubMed ID: 16432501
[TBL] [Abstract][Full Text] [Related]
9. Long-term clenbuterol administration alters the isometric contractile properties of skeletal muscle from normal and dystrophin-deficient mdx mice.
Hayes A; Williams DA
Clin Exp Pharmacol Physiol; 1994 Oct; 21(10):757-65. PubMed ID: 7867226
[TBL] [Abstract][Full Text] [Related]
10. Low dose formoterol administration improves muscle function in dystrophic mdx mice without increasing fatigue.
Harcourt LJ; Schertzer JD; Ryall JG; Lynch GS
Neuromuscul Disord; 2007 Jan; 17(1):47-55. PubMed ID: 17134898
[TBL] [Abstract][Full Text] [Related]
11. Structural and functional characterization of simvastatin-induced myotoxicity in different skeletal muscles.
Simsek Ozek N; Bal IB; Sara Y; Onur R; Severcan F
Biochim Biophys Acta; 2014 Jan; 1840(1):406-15. PubMed ID: 24045089
[TBL] [Abstract][Full Text] [Related]
12. Dystrophin-negative slow-twitch soleus muscles are not susceptible to eccentric contraction induced injury over the lifespan of the
Kiriaev L; Kueh S; Morley JW; Houweling PJ; Chan S; North KN; Head SI
Am J Physiol Cell Physiol; 2021 Oct; 321(4):C704-C720. PubMed ID: 34432537
[TBL] [Abstract][Full Text] [Related]
13. Soleus muscle in glycosylation-deficient muscular dystrophy is protected from contraction-induced injury.
Gumerson JD; Kabaeva ZT; Davis CS; Faulkner JA; Michele DE
Am J Physiol Cell Physiol; 2010 Dec; 299(6):C1430-40. PubMed ID: 20844247
[TBL] [Abstract][Full Text] [Related]
14. Fnip1 regulates skeletal muscle fiber type specification, fatigue resistance, and susceptibility to muscular dystrophy.
Reyes NL; Banks GB; Tsang M; Margineantu D; Gu H; Djukovic D; Chan J; Torres M; Liggitt HD; Hirenallur-S DK; Hockenbery DM; Raftery D; Iritani BM
Proc Natl Acad Sci U S A; 2015 Jan; 112(2):424-9. PubMed ID: 25548157
[TBL] [Abstract][Full Text] [Related]
15. Time course in calpain activity and autolysis in slow and fast skeletal muscle during clenbuterol treatment.
Douillard A; Galbes O; Rossano B; Vernus B; Bonnieu A; Candau R; Py G
Can J Physiol Pharmacol; 2011 Feb; 89(2):117-25. PubMed ID: 21326343
[TBL] [Abstract][Full Text] [Related]
16. Reduced mitochondrial respiration and increased calcium deposits in the EDL muscle, but not in soleus, from 12-week-old dystrophic mdx mice.
Gaglianone RB; Santos AT; Bloise FF; Ortiga-Carvalho TM; Costa ML; Quirico-Santos T; da Silva WS; Mermelstein C
Sci Rep; 2019 Feb; 9(1):1986. PubMed ID: 30760802
[TBL] [Abstract][Full Text] [Related]
17. Rescue of dystrophic skeletal muscle by PGC-1α involves a fast to slow fiber type shift in the mdx mouse.
Selsby JT; Morine KJ; Pendrak K; Barton ER; Sweeney HL
PLoS One; 2012; 7(1):e30063. PubMed ID: 22253880
[TBL] [Abstract][Full Text] [Related]
18. Sarcoplasmic reticulum function in slow- and fast-twitch skeletal muscles from mdx mice.
Divet A; Huchet-Cadiou C
Pflugers Arch; 2002 Aug; 444(5):634-43. PubMed ID: 12194017
[TBL] [Abstract][Full Text] [Related]
19. Extracellular signal-regulated kinase pathway is differentially involved in beta-agonist-induced hypertrophy in slow and fast muscles.
Shi H; Zeng C; Ricome A; Hannon KM; Grant AL; Gerrard DE
Am J Physiol Cell Physiol; 2007 May; 292(5):C1681-9. PubMed ID: 17151143
[TBL] [Abstract][Full Text] [Related]
20. Differentiation of original and regenerated skeletal muscle fibres in mdx dystrophic muscles.
Earnshaw JC; Kyprianou P; Krishan K; Dhoot GK
Histochem Cell Biol; 2002 Jul; 118(1):19-27. PubMed ID: 12122443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
